-
My Account
My Account
BSE Live
Mar 05, 16:00Prev. Close
4574.30
Open Price
4548.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Mar 05, 15:59Prev. Close
4575.05
Open Price
4550.00
Bid Price (Qty.)
4492.50 (759)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Dr Reddys Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 2,775.80 | 1,700.70 | 697.00 | 1,544.50 | 1,580.00 | |
| Net CashFlow From Operating Activities | 1,839.20 | 2,762.10 | 1,538.60 | 1,015.90 | 2,798.20 | |
| Net Cash Used In Investing Activities | -1,689.20 | -550.90 | -1,179.90 | 1,442.50 | -1,961.10 | |
| Net Cash Used From Financing Activities | -224.10 | -2,223.10 | -304.40 | -2,581.80 | -693.70 | |
| Foreign Exchange Gains / Losses | 0.00 | 4.40 | -0.30 | -12.00 | -9.20 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -74.10 | -7.50 | 54.00 | -135.40 | 134.20 | |
| Cash And Cash Equivalents Begin of Year | 113.20 | 120.70 | 66.70 | 202.10 | 60.00 | |
| Cash And Cash Equivalents End Of Year | 39.10 | 113.20 | 120.70 | 66.70 | 194.20 |
02.02.2021
Dr Reddys Labs Standalone December 2020 Net Sales at Rs 3,408.20 crore, up 11.96% Y-o-Y
29.01.2021
Dr Reddy's Labs Q3 profit at Rs 20 crore, revenue rises 12% YoY
29.10.2020
Dr Reddys Labs Consolidated September 2020 Net Sales at Rs 4,910.90 crore, up 2.04% Y-o-Y
29.10.2020
Dr Reddys Labs Standalone September 2020 Net Sales at Rs 3,345.80 crore, down 2.91% Y-o-Y
29.01.2021
22.01.2021
18.01.2021
Dr. Reddy’s Laboratories Q3 PAT may dip 2% YoY to Rs. 781.6 cr: Prabhudas Lilladher
29.07.2020
Dr Reddy's Labs Q1 Preview: Profit may decline on higher base, but revenue can grow over 5%
